A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden is a research paper published in Cell chemical biology (2024). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: K99 AI175674
NCCIH NIH HHS
Grant: R01 AT009741
NIGMS NIH HHS
Grant: R25 GM103757
NIDDK NIH HHS
Grant: T32 DK077653
NIGMS NIH HHS
Grant: T34 GM141639
NCI NIH HHS
Grant: P30 CA091842
NCCIH NIH HHS
Grant: K99 AT012651
NIAID NIH HHS
Grant: R01 AI155893
NIGMS NIH HHS
Grant: T32 GM007067
NCI NIH HHS
Grant: T32 CA113275
National Center for Complementary and Integrative Health
National Cancer Institute Division of Cancer Prevention
National Institute of Allergy and Infectious Diseases Division of Intramural Research
National Institute of Child Health and Human Development
National Institute of General Medical Sciences
National Institute of Diabetes and Digestive and Kidney Diseases
Radiological Society of North America
FWCI
5.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals